EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Contradictory Role of Gadd45β in Liver Diseases

Chi Wu iD, Xiaozhen Song, Miaoxin Zhang, Longjun Yang, Panpan Lu, Qiang Ding iD, Mei Liu iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70267 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Chi Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Antigens, Differentiation, Liver Diseases, GADD45 Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Hubei Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are three homologous proteins (α, β and γ) in the growth arrest and DNA damage 45 (Gadd45) family. These proteins act as cellular responders to physiological and environmental stimuli. Gadd45β plays a significant role in the pathogenesis of liver diseases. Liver injury and growth stimulation increase expression of Gadd45β, which promotes cell survival, growth and proliferation in normal liver cells. By contrast, Gadd45β plays a role in promoting apoptosis and inhibiting tumour function in hepatocellular carcinoma (HCC). Currently, it is believed that Gadd45β benefits the liver through two different pathways: binding to MAPK kinase 6 (MKK6) to increase PCD induced by p38 (inhibiting tumours) or binding to constitutive androstane receptor (CAR) to jointly activate transcription of liver synthesis metabolism (promoting liver regeneration). This article aims to systematically review the role of Gadd45β in liver diseases, including its regulatory mechanism on expression and involvement in liver cell damage, inflammation, fibrosis and HCC. In conclusion, we explore the potential of targeting Gadd45β as a therapeutic strategy for liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, DifferentiationLiver DiseasesGADD45 ProteinsAnimalsHumansApoptosisCarcinoma, HepatocellularCell ProliferationLiverLiver NeoplasmsSignal Transduction

Stichwörter der Autor:innen

Gadd45βfatty liverhepatocellular carcinomahepatocellular damageliver fibrosis

Substanzen

Antigens, DifferentiationGADD45B protein, humanGADD45 Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Chi Wu, Qiang Ding, Mei Liu

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Projects of Hubei Province, China

Zitieren

APA

Wu, C., Song, X., Zhang, M., Yang, L., Lu, P., Ding, Q., & Liu, M. (2024). Contradictory Role of Gadd45β in Liver Diseases. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70267

Vancouver

Wu C, Song X, Zhang M, Yang L, Lu P, Ding Q, et al. Contradictory Role of Gadd45β in Liver Diseases. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70267

BibTeX
@article{Wu2024,
  author = {Wu, Chi and Song, Xiaozhen and Zhang, Miaoxin and Yang, Longjun and Lu, Panpan and Ding, Qiang and Liu, Mei},
  title = {Contradictory Role of Gadd45β in Liver Diseases},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70267}
}
Kostenlos starten →